ATXN1L | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

22 results for “ATXN1L”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

EASE (Efficacy of ATX01 Study in Erythromelalgia)

14 participants · First posted Jun 26, 2023

Active, not recruiting

Efficacy and Safety of ATX01 in Adult Patients With CIPN (Chemotherapy-induced Peripheral Neuropathy)

276 participants · First posted Oct 25, 2022

Active, not recruiting

Study of ARO-ATXN2 Injection in Adults With Spinocerebellar Ataxia Type 2

39 participants · First posted Nov 4, 2024

Active, not recruiting

Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation

1 participants · First posted Jul 24, 2025

Active, not recruiting

Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation

1 participants · First posted Oct 28, 2025

Active, not recruiting

Personalized Antisense Oligonucleotide Therapy for a Single Participant with ATN1 Gene Mutation

1 participants · First posted Nov 26, 2024

A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

99 participants · First posted Jul 31, 2020